Yahoo España Búsqueda web

Search results

  1. Hace 5 días · Site Name: Mexico City Torre MitikahPosted Date: Jul 18 2024The Brand Manager Vx is responsible for…Ve este y otros empleos similares en LinkedIn. Pasar al contenido principal LinkedIn. Director de marca en Boydton, VA ... Solicitar empleo de Brand Manager Vx en GSK.

  2. Hace 1 día · GSK announces the acceptance of its regulatory filing, seeking the approval of Blenrep combinations for the treatment of relapsed or refractory multiple myeloma, for review in the EU.

  3. Hace 1 día · The European Medicines Agency (EMA) has accepted for review GSK ’s marketing authorisation application (MAA) for Blenrep (belantamab mafodotin), an antibody-drug conjugate (ADC), to treat relapsed or refractory multiple myeloma (r/r MM). The ADC is intended for use in combination with bortezomib plus dexamethasone (BorDex) or pomalidomide ...

  4. Hace 4 días · GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for Blenrep (belantamab mafodotin) in combination with bortezomib plus dexamethasone (BorDex) or pomalidomide plus dexamethasone (PomDex) as a treatment for relapsed or refractory multiple myeloma.

  5. Hace 1 día · GSK lanza en México campaña de concientización contra el herpes zóster 22 Feb; Nuevo campus Ciencias de la Salud del Tec de Monterrey impulsará formación médica e investigación científica de primer nivel 22 Feb; Cofepris presenta agenda de fortalecimiento de la industria de dispositivos médicos 21 Feb

  6. 15 de jul. de 2024 · Latest GSK plc (GSK:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

  7. Hace 4 días · GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.